BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 16261150)

  • 1. Protocol audits for post-approval monitoring of animal use protocols.
    Smelser JF; Gardella SL; Austin BL
    Lab Anim (NY); 2005 Nov; 34(10):23-7. PubMed ID: 16261150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Going through the phases. Response: Post-approval monitoring.
    Bair J
    Lab Anim (NY); 2009 May; 38(5):143-4. PubMed ID: 19384306
    [No Abstract]   [Full Text] [Related]  

  • 3. Revisiting approved protocols: IACUC should discuss.
    Bell JH; Scorpio D
    Lab Anim (NY); 2010 Jun; 39(6):166-7. PubMed ID: 20485351
    [No Abstract]   [Full Text] [Related]  

  • 4. Revisiting approval protocols: approval should stand.
    Williams MK
    Lab Anim (NY); 2010 Jun; 39(6):165-6. PubMed ID: 20485349
    [No Abstract]   [Full Text] [Related]  

  • 5. Revisiting approval protocols: re-review not required.
    Yamada KP; Prestia K; Dholakia U; Shoulson R
    Lab Anim (NY); 2010 Jun; 39(6):166. PubMed ID: 20485352
    [No Abstract]   [Full Text] [Related]  

  • 6. A tool for semiannual review of the institutional animal care and use program.
    McEntee HI; Sandgren EP
    Lab Anim (NY); 2007 Oct; 36(9):36-40. PubMed ID: 17885662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting approved protocols.
    Lab Anim (NY); 2010 Jun; 39(6):165. PubMed ID: 20485350
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical blood draws: when do they require IACUC approval?
    Pritt S; Nostrant JF; Samalonis P; Lotocki B; Harrison RM
    Lab Anim (NY); 2004 Jan; 33(1):17-21. PubMed ID: 14752527
    [No Abstract]   [Full Text] [Related]  

  • 9. Tackling investigator noncompliance.
    Lab Anim (NY); 2006 Nov; 35(10):15. PubMed ID: 17077825
    [No Abstract]   [Full Text] [Related]  

  • 10. Tackling investigator noncompliance: Stop and investigate.
    McMickle A; Buchanan R
    Lab Anim (NY); 2006 Nov; 35(10):17. PubMed ID: 17077828
    [No Abstract]   [Full Text] [Related]  

  • 11. Tackling investigator noncompliance: Decide now.
    Jackson TA
    Lab Anim (NY); 2006 Nov; 35(10):16. PubMed ID: 17077827
    [No Abstract]   [Full Text] [Related]  

  • 12. Tackling investigator noncompliance: Cooperation counts.
    Breedlove M; Light S; Parks C; Greene M
    Lab Anim (NY); 2006 Nov; 35(10):16-7. PubMed ID: 17077826
    [No Abstract]   [Full Text] [Related]  

  • 13. Tackling investigator noncompliance: Suspend the surgeries.
    Wadsworth K
    Lab Anim (NY); 2006 Nov; 35(10):15-6. PubMed ID: 17077824
    [No Abstract]   [Full Text] [Related]  

  • 14. IACUC approval of SOPs.
    Lab Anim (NY); 2012 Jan; 41(2):41. PubMed ID: 22261885
    [No Abstract]   [Full Text] [Related]  

  • 15. Tackling investigator noncompliance: a word from OLAW and USDA.
    Brown P; Gipson C
    Lab Anim (NY); 2006 Nov; 35(10):18. PubMed ID: 17077829
    [No Abstract]   [Full Text] [Related]  

  • 16. AALAS position statement on the humane care and use of laboratory animals.
    American Association for Laboratory Animal Science
    Comp Med; 2007 Aug; 57(4):413. PubMed ID: 17803057
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to refusal to renew an expiring protocol: IACUC acted appropriately, but..
    Richerson JT
    Lab Anim (NY); 2010 Nov; 39(11):336-7. PubMed ID: 20962757
    [No Abstract]   [Full Text] [Related]  

  • 18. Going through the phases. Response: Approve and monitor.
    Daugherity E
    Lab Anim (NY); 2009 May; 38(5):144. PubMed ID: 19384308
    [No Abstract]   [Full Text] [Related]  

  • 19. Grants proposals and animal use protocols: is the IACUC playing by the rules? A word from OLAW.
    Wigglesworth C
    Lab Anim (NY); 2006 Feb; 35(2):18. PubMed ID: 16446731
    [No Abstract]   [Full Text] [Related]  

  • 20. Revisiting approach protocols: a word from OLAW and USDA.
    Brown P; Gipson C
    Lab Anim (NY); 2010 Jun; 39(6):167. PubMed ID: 20485353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.